Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01MH137799 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Mental Health (NIMH) | NIH |
| Infectious Diseases Research Collaboration, Uganda | OTHER |
| University of California, Berkeley | OTHER |
Not provided
Not provided
Not provided
Not provided
This study will refine and pilot test the Peer-led Dynamic Choice HIV Prevention (DCP) intervention in a single-arm pilot trial. The study will test the hypothesis that the Peer-led Dynamic Choice HIV Prevention intervention will be feasible and increase biomedical HIV prevention coverage in the 6 months after receipt of the Peer-led DCP intervention compared to the standard of care in the 6 months prior to intervention implementation.
The overall goal of this study is to refine and pilot test a Peer-led Dynamic Choice HIV Prevention intervention tailored to women at elevated HIV risk in southwestern Uganda. We will conduct a single-arm pilot trial of the intervention enrolling approximately 60 women to assess the feasibility, acceptability, and preliminary effectiveness of the Peer-led Dynamic Choice Prevention intervention.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Peer-led Dynamic Choice HIV Prevention (DCP) intervention | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Peer-led Dynamic Choice HIV Prevention (DCP) intervention | Other | The intervention consists of peer mentor training on patient-centered choice counseling and Peer-led DCP services, and will be delivered by the peer mentor with clinician support:
|
| Measure | Description | Time Frame |
|---|---|---|
| Biomedical HIV prevention coverage | Percentage of follow-up months that a participant uses a biomedical HIV prevention product | 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| At-risk biomedical HIV prevention coverage | Percentage of at-risk follow-up months that a participant uses a biomedical HIV prevention product | 24 weeks |
| Feasibility of delivery of the Peer-Led DCP intervention by peers |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Female sex at birth
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Catherine Koss, MD | Contact | 415-476-4082 | catherine.koss@ucsf.edu | |
| Lisa Georgetti Gomez, MSPH | Contact | 415-539-5688 | lisa.georgetti@ucsf.edu |
| Name | Affiliation | Role |
|---|---|---|
| Catherine Koss, MD | University of California, San Francisco | Principal Investigator |
| Jane Kabami, MPH, PhD(c) | Infectious Diseases Research Collaboration | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Infectious Diseases Research Collaboration | Recruiting | Kampala | Uganda |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000163 | Acquired Immunodeficiency Syndrome |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D008722 | Methods |
| ID | Term |
|---|---|
| D008919 | Investigative Techniques |
Not provided
Not provided
Single-arm pilot trial to refine and pilot test the Peer-led DCP intervention.
Not provided
Not provided
Not provided
Not provided
|
Proportion of participants with Peer-led DCP intervention services delivered by peer mentor
| 24 weeks |
| D015229 |
| Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012897 | Slow Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |